LGALS1 and cancer: Although the precise regulation of Gal-1 expression remains incompletely understood, changes in its expression have been observed in a range of pathological conditions, including inflammatory diseases (e.g., tissue injuries, fibrosis, and autoimmune disorders) and cancers [38].